PCA3 molecular urine assay for prostate cancer: association with pathologic features and impact of collection protocols

摘要

Introduction PCA3 is a non-coding mRNA molecule that is overexpressed in prostate cancer. The purpose of this study is to evaluate the utility of the PCA3 molecular urine test scores to predict adverse pathologic features and catheterized specimen collection.